We don’t start from the ground floor.
Berolink builds the interface between species. It begins with pain in dogs, and it does not end there — it ends the day an animal can say what it wants.
Every discipline the next generation of animal neurotechnology demands is already inside this company.
What we already hold
SDILS — a self-driven interactive learning system for learning from beings that have no language — is Berolink’s own architecture, patented in the United States, where it was recognised as exceptional. It is what turns a signal into meaning rather than a label.
BeroAI, our sister company, builds personalised AI for animals — an individual’s character, and the causes behind what they do. Its pipeline, its simulator and its decoding stack come to Berolink.
A company that touches an animal’s brain lives or dies on trust.
So ethics is not an appendix at Berolink — it is the first design principle. An independent welfare and neuroethics board — veterinary neurologists, animal-welfare scientists, neuroethicists, legal counsel — is part of the company by design from day one, and the regulatory path is drawn alongside the science, not after it.
The welfare & neuroethics board is being formed; members are not named until appointed.
Understanding, not control. We relieve, we don’t manipulate. The first thing we do is end pain.
The animal holds a veto. We read its response as we act, and stop the moment it refuses. The animal is always in the loop.
Reversible, and tapering. Nothing permanent is injected; and success is the day our signal is no longer needed.
Animal benefit only. Every stage is unambiguously good for the animal — not human convenience or curiosity.
Safe by medical standards. Safety, biocompatibility and reversibility held to surgical and research-ethics standards.
Honest output. Confidence and evidence together; never a certainty the signal can’t support.
When welfare and depth collide, depth yields.